Allworth Financial’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7K Sell
1,506
-574
-28% -$6.41K ﹤0.01% 3385
2026
Q1
$24.8K Buy
2,080
+1,309
+170% +$13.4K ﹤0.01% 2834
2025
Q4
$7.68K Buy
771
+40
+5% +$382 ﹤0.01% 3437
2025
Q3
$6.54K Buy
731
+207
+40% +$1.92K ﹤0.01% 3391
2025
Q2
$4.94K Buy
524
+283
+117% +$2.5K ﹤0.01% 3265
2025
Q1
$1.94K Buy
241
+13
+6% +$131 ﹤0.01% 3233
2024
Q4
$2.32K Sell
228
-32
-12% -$324 ﹤0.01% 3106
2024
Q3
$2.92K Buy
260
+32
+14% +$340 ﹤0.01% 2794
2024
Q2
$2.43K Hold
228
– – ﹤0.01% 2838
2024
Q1
$2.63K Sell
228
-203
-47% -$1.72K ﹤0.01% 2709
2023
Q4
$3.14K Buy
431
+298
+224% +$2.35K ﹤0.01% 2467
2023
Q3
$1.21K Buy
133
+32
+32% +$384 ﹤0.01% 2765
2023
Q2
$1.23K Buy
101
+23
+29% +$256 ﹤0.01% 2662
2023
Q1
$970 Buy
+78
New +$1.44K ﹤0.01% 2680
2022
Q4
– Sell
-15
Closed – – 2997
2022
Q3
$0 Hold
15
– – ﹤0.01% 2619
2022
Q2
$0 Buy
+15
New +$244 ﹤0.01% 2348

Other funds holding AHCO

Allworth Financial's AHCO Position: Q2 2026 in Review

Allworth Financial reduced its AdaptHealth (AHCO) stake by 28% in Q2 2026, selling an estimated $6.41K and leaving 1,506 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3385.

Allworth Financial first reported a position in AHCO in Q2 2022 and has held it in 16 quarters since. The position peaked at $24.8K in Q1 2026. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Allworth Financial held 1,506 shares of AdaptHealth worth $15.7K as of Q2 2026.
  • Allworth Financial sold 574 AdaptHealth shares in Q2 2026, an estimated $6.41K.
  • AdaptHealth made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3385 holding.
  • Allworth Financial first reported a position in AdaptHealth in Q2 2022 and has held it in 16 quarters since.
  • Allworth Financial's AdaptHealth position peaked at $24.8K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.